LA / BNB

WAXP / BTC

ARPA / BTC

HUMA / BNB

LA / USDT

LA / TRY

LA / USDC

JST / BTC

HOLO / FDUSD

HOLO / USDC

GALA / BTC

BAKE / USDT

BAKE / TRY

BAKE / BTC

HOT / ETH

SLF / TRY

SLF / USDC

SLF / BTC

GMT / BTC

KMNO / USDT

DC INFOTECH AND COMUN LTD

NAGREEKA EXPORTS LTD.

SHRE PUSH CHEM & FERT LTD

DIGISPICE TECHNOLOGIES LT

ASHAPURA LOGISTICS LTD

P S RAJ STEELS LIMITED

CLASSIC ELECTRODE (IND) L

GMR POW AND URBAN INFRA L

SACHEEROME LIMITED

BANCO PRODUCTS (I) LTD

GIRIRAJ CIVIL DEVP LTD

SUNREST LIFESCIENCE LTD

KRBL LIMITED

GSM FOILS LTD

LAMBODHARA TEXTILES LTD.

GAYATRI RUBB AND CHEM LTD

INSPIRE FILMS LIMITED

AVONMORE CAP&MGT SERV LTD

BHADORA INDUSTRIES LTD

GEM AROMATICS LIMITED

Click here to get full coverage on The FDA Is Cracking Down on an Indian Drugmaker Investigated by ProPublica Last Year - ProPublica

The FDA Is Cracking Down on an Indian Drugmaker Investigated by ProPublica Last Year  ProPublica

The FDA Is Cracking Down on an Indian Drugmaker Investigated by ProPublica Last Year - ProPublica

Click here to get full coverage on Glenmark, Indraprastha Gas among 7 key companies to trade ex-dividend today, 15 September 2025 - Mint

Glenmark, Indraprastha Gas among 7 key companies to trade ex-dividend today, 15 September 2025  Mint

Glenmark, Indraprastha Gas among 7 key companies to trade ex-dividend today, 15 September 2025 - Mint

Click here to get full coverage on Glenmark Pharma to transfer its consumer care biz to Glenmark Consumer Care - Business Standard

Glenmark Pharma to transfer its consumer care biz to Glenmark Consumer Care  Business Standard

Glenmark Pharma to transfer its consumer care biz to Glenmark Consumer Care - Business Standard

Click here to get full coverage on India's Glenmark Pharma soars 10% to record high on AbbVie cancer treatment licensing deal - Reuters

India's Glenmark Pharma soars 10% to record high on AbbVie cancer treatment licensing deal  Reuters

India's Glenmark Pharma soars 10% to record high on AbbVie cancer treatment licensing deal - Reuters

Click here to get full coverage on Alembic, Sun and Glenmark issue US drug recalls due to the presence of carcinogens or foreign matter - Fierce Pharma

Alembic, Sun and Glenmark issue US drug recalls due to the presence of carcinogens or foreign matter  Fierce Pharma

Alembic, Sun and Glenmark issue US drug recalls due to the presence of carcinogens or foreign matter - Fierce Pharma

Click here to get full coverage on Glenmark Shares Rise on $700M AbbVie Licensing Deal, With $1.2B Milestones Ahead - HDFC Sky

Glenmark Shares Rise on $700M AbbVie Licensing Deal, With $1.2B Milestones Ahead  HDFC Sky

Glenmark Shares Rise on $700M AbbVie Licensing Deal, With $1.2B Milestones Ahead - HDFC Sky

Click here to get full coverage on FDA warns Glenmark for failure to investigate dissolution failures - Regulatory Affairs Professionals Society | RAPS

FDA warns Glenmark for failure to investigate dissolution failures  Regulatory Affairs Professionals Society | RAPS

FDA warns Glenmark for failure to investigate dissolution failures - Regulatory Affairs Professionals Society | RAPS

Click here to get full coverage on Dividend Stocks To Watch This Week — Glenmark Pharma, Dixon Tech, Hindustan Copper And More - NDTV Profit

Dividend Stocks To Watch This Week — Glenmark Pharma, Dixon Tech, Hindustan Copper And More  NDTV Profit

Dividend Stocks To Watch This Week — Glenmark Pharma, Dixon Tech, Hindustan Copper And More - NDTV Profit

Click here to get full coverage on AbbVie to pay $700M for trispecific drug from Ichnos Glenmark - BioPharma Dive

AbbVie to pay $700M for trispecific drug from Ichnos Glenmark  BioPharma Dive

AbbVie to pay $700M for trispecific drug from Ichnos Glenmark - BioPharma Dive

Click here to get full coverage on AbbVie and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody - PR Newswire

AbbVie and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody  PR Newswire

AbbVie and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody - PR Newswire

Click here to get full coverage on Glenmark, J. K. Cement among top losers on Nifty Midcap 150 - TradingView

Glenmark, J. K. Cement among top losers on Nifty Midcap 150  TradingView

Glenmark, J. K. Cement among top losers on Nifty Midcap 150 - TradingView

Click here to get full coverage on AbbVie steps up for Glenmark's multispecific | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

AbbVie steps up for Glenmark's multispecific | ApexOnco - Clinical Trials news and analysis  Oncology Pipeline

AbbVie steps up for Glenmark's multispecific | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Click here to get full coverage on Latham & Watkins Advises AbbVie on US$1.925 Billion Licensing Agreement With Ichnos Glenmark Innovation - Latham & Watkins LLP

Latham & Watkins Advises AbbVie on US$1.925 Billion Licensing Agreement With Ichnos Glenmark Innovation  Latham & Watkins LLP

Latham & Watkins Advises AbbVie on US$1.925 Billion Licensing Agreement With Ichnos Glenmark Innovation - Latham & Watkins LLP

Click here to get full coverage on Stocks to buy this week: IREDA, BEL among 7 stocks with potential upside of up to 21% - The Economic Times

Stocks to buy this week: IREDA, BEL among 7 stocks with potential upside of up to 21%  The Economic Times

Stocks to buy this week: IREDA, BEL among 7 stocks with potential upside of up to 21% - The Economic Times

Click here to get full coverage on AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B - BioSpace

AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B  BioSpace

AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B - BioSpace

Click here to get full coverage on India's Glenmark Pharma unit, AbbVie sign exclusive licensing pact - Reuters

India's Glenmark Pharma unit, AbbVie sign exclusive licensing pact  Reuters

India's Glenmark Pharma unit, AbbVie sign exclusive licensing pact - Reuters

Click here to get full coverage on An Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients - ProPublica

An Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients  ProPublica

An Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients - ProPublica

Click here to get full coverage on Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) - PR Newswire

Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)  PR Newswire

Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) - PR Newswire

Click here to get full coverage on Glenmark Initiates a Multi-Country Phase 3 Clinical Trial for Envafolimab in Resectable Stage III Non-Small Cell Lung Cancer - PR Newswire

Glenmark Initiates a Multi-Country Phase 3 Clinical Trial for Envafolimab in Resectable Stage III Non-Small Cell Lung Cancer  PR Newswire

Glenmark Initiates a Multi-Country Phase 3 Clinical Trial for Envafolimab in Resectable Stage III Non-Small Cell Lung Cancer - PR Newswire

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial) - PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial)  PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial) - PR Newswire

Click here to get full coverage on 26 Dividend Stocks: Glenmark Pharma, Indraprastha Gas, Phoenix Mills — Last Day To Buy Shares To Qualify - NDTV Profit

26 Dividend Stocks: Glenmark Pharma, Indraprastha Gas, Phoenix Mills — Last Day To Buy Shares To Qualify  NDTV Profit

26 Dividend Stocks: Glenmark Pharma, Indraprastha Gas, Phoenix Mills — Last Day To Buy Shares To Qualify - NDTV Profit

Click here to get full coverage on Texmaco Rail, IGL, Glenmark among stocks to turn ex-dividend on Monday, September 15 - MSN

Texmaco Rail, IGL, Glenmark among stocks to turn ex-dividend on Monday, September 15  MSN

Texmaco Rail, IGL, Glenmark among stocks to turn ex-dividend on Monday, September 15 - MSN

Click here to get full coverage on Know Worldwide specifications of the Cetirizine Hydrochloride - openPR.com

Know Worldwide specifications of the Cetirizine Hydrochloride  openPR.com

Know Worldwide specifications of the Cetirizine Hydrochloride - openPR.com

Click here to get full coverage on Glenmark shares gain 2% as firm receives $700 million upfront payment from AbbVie deal - The Economic Times

Glenmark shares gain 2% as firm receives $700 million upfront payment from AbbVie deal  The Economic Times

Glenmark shares gain 2% as firm receives $700 million upfront payment from AbbVie deal - The Economic Times

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials - PR Newswire

Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials  PR Newswire

Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials - PR Newswire

Click here to get full coverage on Glenmark, Texmaco Rail shares in focus on the last day to buy for dividend eligibility - The Economic Times

Glenmark, Texmaco Rail shares in focus on the last day to buy for dividend eligibility  The Economic Times

Glenmark, Texmaco Rail shares in focus on the last day to buy for dividend eligibility - The Economic Times

Click here to get full coverage on Glenmark shares fall 1.81%; stock among top losers on Nifty Midcap 150 - Moneycontrol

Glenmark shares fall 1.81%; stock among top losers on Nifty Midcap 150  Moneycontrol

Glenmark shares fall 1.81%; stock among top losers on Nifty Midcap 150 - Moneycontrol

Click here to get full coverage on Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) - PR Newswire

Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)  PR Newswire

Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) - PR Newswire

Click here to get full coverage on OpenAI Unveils Financial Details of Restructuring Plan, New Deal With Microsoft - PYMNTS.com

OpenAI Unveils Financial Details of Restructuring Plan, New Deal With Microsoft  PYMNTS.com

OpenAI Unveils Financial Details of Restructuring Plan, New Deal With Microsoft - PYMNTS.com

Click here to get full coverage on Glenmark Recalls Nearly 1.5 Million Bottles of ADHD Drug Atomoxetine - MedCentral

Glenmark Recalls Nearly 1.5 Million Bottles of ADHD Drug Atomoxetine  MedCentral

Glenmark Recalls Nearly 1.5 Million Bottles of ADHD Drug Atomoxetine - MedCentral

Click here to get full coverage on Tesla robotaxi, AbbVie licenses Glenmark cancer drug, McDonald's - Yahoo Finance

Tesla robotaxi, AbbVie licenses Glenmark cancer drug, McDonald's  Yahoo Finance

Tesla robotaxi, AbbVie licenses Glenmark cancer drug, McDonald's - Yahoo Finance

Click here to get full coverage on Glenmark, Alembic Pharma, Sun Pharma recall products in US: USFDA - The Economic Times

Glenmark, Alembic Pharma, Sun Pharma recall products in US: USFDA  The Economic Times

Glenmark, Alembic Pharma, Sun Pharma recall products in US: USFDA - The Economic Times

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial) - PR Newswire

Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial)  PR Newswire

Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial) - PR Newswire

Click here to get full coverage on The FDA Finally Visited an Indian Drug Factory Linked to U.S. Deaths. It Found Problems. - ProPublica

The FDA Finally Visited an Indian Drug Factory Linked to U.S. Deaths. It Found Problems.  ProPublica

The FDA Finally Visited an Indian Drug Factory Linked to U.S. Deaths. It Found Problems. - ProPublica

Click here to get full coverage on AstraZeneca refused interim injunction on SPC for blockbuster diabetes treatment against Glenmark but swiftly obtains permission to appeal - A&O Shearman

AstraZeneca refused interim injunction on SPC for blockbuster diabetes treatment against Glenmark but swiftly obtains permission to appeal  A&O Shearman

AstraZeneca refused interim injunction on SPC for blockbuster diabetes treatment against Glenmark but swiftly obtains permission to appeal - A&O Shearman

Click here to get full coverage on Glenmark shares higher as subsidiary gets $700 million from NYSE-listed AbbVie in licensing deal - Moneycontrol

Glenmark shares higher as subsidiary gets $700 million from NYSE-listed AbbVie in licensing deal  Moneycontrol

Glenmark shares higher as subsidiary gets $700 million from NYSE-listed AbbVie in licensing deal - Moneycontrol

Click here to get full coverage on Glenmark gains 3% on $700 mn upfront payment from AbbVie licensing deal - Business Standard

Glenmark gains 3% on $700 mn upfront payment from AbbVie licensing deal  Business Standard

Glenmark gains 3% on $700 mn upfront payment from AbbVie licensing deal - Business Standard

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial - PR Newswire

Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial  PR Newswire

Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial - PR Newswire

Click here to get full coverage on Glenmark, Alembic Pharma, Sun Pharma shares slip up to 1.5% on product recalls after USFDA action - The Economic Times

Glenmark, Alembic Pharma, Sun Pharma shares slip up to 1.5% on product recalls after USFDA action  The Economic Times

Glenmark, Alembic Pharma, Sun Pharma shares slip up to 1.5% on product recalls after USFDA action - The Economic Times

Click here to get full coverage on Glenmark Pharma says unit Ichnos Glenmark Innovation received upfront payment of $700 million from AbbVie - MarketScreener

Glenmark Pharma says unit Ichnos Glenmark Innovation received upfront payment of $700 million from AbbVie  MarketScreener

Glenmark Pharma says unit Ichnos Glenmark Innovation received upfront payment of $700 million from AbbVie - MarketScreener

Click here to get full coverage on Nationwide Recall Hits Dozens of Common Generic Drugs—What You Need to Know - health.com

Nationwide Recall Hits Dozens of Common Generic Drugs—What You Need to Know  health.com

Nationwide Recall Hits Dozens of Common Generic Drugs—What You Need to Know - health.com

Click here to get full coverage on Glenmark, J. K. Cement among top losers on Nifty Midcap 150 - Moneycontrol

Glenmark, J. K. Cement among top losers on Nifty Midcap 150  Moneycontrol

Glenmark, J. K. Cement among top losers on Nifty Midcap 150 - Moneycontrol

Click here to get full coverage on Glenmark Pharma shares surge after its U.S arm, AbbVie ink pact for investigational cancer drug - The Hindu

Glenmark Pharma shares surge after its U.S arm, AbbVie ink pact for investigational cancer drug  The Hindu

Glenmark Pharma shares surge after its U.S arm, AbbVie ink pact for investigational cancer drug - The Hindu

Click here to get full coverage on FDA Warns Glenmark Pharmaceuticals Over Drug Safety - Legal Reader

FDA Warns Glenmark Pharmaceuticals Over Drug Safety  Legal Reader

FDA Warns Glenmark Pharmaceuticals Over Drug Safety - Legal Reader

Click here to get full coverage on Dividend stocks: NSDL, Glenmark Pharma, Dixon Tech, Mazagon Dock, SJVN, and others to trade ex-dividend this week - financialexpress.com

Dividend stocks: NSDL, Glenmark Pharma, Dixon Tech, Mazagon Dock, SJVN, and others to trade ex-dividend this week  financialexpress.com

Dividend stocks: NSDL, Glenmark Pharma, Dixon Tech, Mazagon Dock, SJVN, and others to trade ex-dividend this week - financialexpress.com

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 10 mg, 15 mg, 20 mg and 30 - PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 10 mg, 15 mg, 20 mg and 30  PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 10 mg, 15 mg, 20 mg and 30 - PR Newswire

Click here to get full coverage on No damages for Glenmark in battle over Mundipharma’s Targin - JUVE Patent

No damages for Glenmark in battle over Mundipharma’s Targin  JUVE Patent

No damages for Glenmark in battle over Mundipharma’s Targin - JUVE Patent

Click here to get full coverage on Glenmark subsidiary gets $700 Million in licensing deal; stock gains - India Infoline

Glenmark subsidiary gets $700 Million in licensing deal; stock gains  India Infoline

Glenmark subsidiary gets $700 Million in licensing deal; stock gains - India Infoline

Click here to get full coverage on Glenmark Pharma shares in focus as Q1 profit slumps 86% YoY - The Economic Times

Glenmark Pharma shares in focus as Q1 profit slumps 86% YoY  The Economic Times

Glenmark Pharma shares in focus as Q1 profit slumps 86% YoY - The Economic Times

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA launches Clindamycin Phosphate Foam, 1% - PR Newswire

Glenmark Pharmaceuticals Inc., USA launches Clindamycin Phosphate Foam, 1%  PR Newswire

Glenmark Pharmaceuticals Inc., USA launches Clindamycin Phosphate Foam, 1% - PR Newswire

Click here to get full coverage on Glenmark Unit to License Blood Cancer Drug to Abbvie for $700 Million Upfront - Bloomberg.com

Glenmark Unit to License Blood Cancer Drug to Abbvie for $700 Million Upfront  Bloomberg.com

Glenmark Unit to License Blood Cancer Drug to Abbvie for $700 Million Upfront - Bloomberg.com

Click here to get full coverage on Glenmark Pharmaceuticals' USA arm reaches $37.75 million settlement in US antitrust lawsuit - CNBC TV18

Glenmark Pharmaceuticals' USA arm reaches $37.75 million settlement in US antitrust lawsuit  CNBC TV18

Glenmark Pharmaceuticals' USA arm reaches $37.75 million settlement in US antitrust lawsuit - CNBC TV18

Click here to get full coverage on Glenmark initiates multi-nation Phase 3 clinical trial for lung cancer drug - The Economic Times

Glenmark initiates multi-nation Phase 3 clinical trial for lung cancer drug  The Economic Times

Glenmark initiates multi-nation Phase 3 clinical trial for lung cancer drug - The Economic Times

Click here to get full coverage on Glenmark Therapeutics Inc., USA launches Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC) - PR Newswire

Glenmark Therapeutics Inc., USA launches Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC)  PR Newswire

Glenmark Pharmaceuticals Limited (GLENMARK)

Price Chart

Key Statistics

Technicals

About GLENMARK

Latest News

The FDA Is Cracking Down on an Indian Drugmaker Investigated by ProPublica Last Year - ProPublica

Glenmark, Indraprastha Gas among 7 key companies to trade ex-dividend today, 15 September 2025 - Mint

Glenmark Pharma to transfer its consumer care biz to Glenmark Consumer Care - Business Standard

Advanced Charts

Top Gainers

Top Losers